A large-scale RNA interference screen identifies genes that regulate autophagy at different stages.

Area of Science:

• Oncology
• Cell Biology
• Molecular Genetics

Background:

• Dysregulated autophagy is a key factor in cancer development and treatment.
• Understanding autophagy regulation in cancer is essential for developing new therapies.
• The specific genes that control autophagy in cancer cells are not fully identified.

Purpose of the Study:

• To identify novel genes that regulate autophagy in cancer.
• To understand the mechanisms by which these genes influence autophagy.
• To explore new therapeutic strategies targeting autophagy in cancer.

Main Methods:

• A large-scale RNA interference screen was conducted in K562 human chronic myeloid leukemia cells.
• Monodansylcadaverine staining coupled with fluorescence-activated cell sorting was used to detect autophagic cells.
• Candidate gene validation involved Cyto-ID fluorescence spectrophotometry, LC3B immunoblotting, and quantitative RT-PCR.

Main Results:

• The screen identified 336 short hairpin RNAs, leading to the validation of 82 autophagy-regulating genes.
• Of these, 62 genes are novel mediators of autophagy, with 20 previously reported.
• Bioinformatic analysis indicated that most identified genes regulate autophagy through associated molecular pathways.
• Autophagy flux assays revealed 57 genes suppress autophagy initiation and 21 promote autophagy maturation.

Conclusions:

• This study successfully identified numerous genes that regulate autophagy at different stages.
• The findings provide a deeper understanding of autophagy regulation in cancer.
• The identified genes offer potential new targets for developing novel autophagy-related cancer therapies.